Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.

Mauz V, Steinacher C, Burhenne J, Steimel K, Mertens C, Muckenthaler MU, Dewenter M, Backs J

DOI: 10.1016/j.jmccpl.2026.100863
Published: 2026 Dec
Container: Journal of molecular and cellular cardiology plus
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jmccpl.2026.100863,
  title = {Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.},
  author = {Mauz V and Steinacher C and Burhenne J and Steimel K and Mertens C and Muckenthaler MU and Dewenter M and Backs J},
  year = {2026},
  journal = {Journal of molecular and cellular cardiology plus},
  doi = {10.1016/j.jmccpl.2026.100863},
  url = {https://doi.org/10.1016/j.jmccpl.2026.100863}
}

RIS

TY  - JOUR
TI  - Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.
AU  - Mauz V
AU  - Steinacher C
AU  - Burhenne J
AU  - Steimel K
AU  - Mertens C
AU  - Muckenthaler MU
AU  - Dewenter M
AU  - Backs J
PY  - 2026
JO  - Journal of molecular and cellular cardiology plus
DO  - 10.1016/j.jmccpl.2026.100863
UR  - https://doi.org/10.1016/j.jmccpl.2026.100863
ER  -

APA

V, M., C, S., J, B., K, S., C, M., MU, M., M, D., & J, B. (2026). Systemic administration of the PRMT5 inhibitor GSK3326595 does not induce overt cardiotoxicity in the murine heart.. Journal of molecular and cellular cardiology plus. https://doi.org/10.1016/j.jmccpl.2026.100863

Source records

pubmed · retrieved 2026-09-26T06:54:34.536Z